Truncation Products Of Stromal Cell Derived Factor-1 (Cxcl12) Quantified By Mass Spectrometry In Patients With Myelodysplastic Syndrome (Mds) Or Acute Myeloid Leukemia (Aml) Treated With Rigosertib In A Phase I-Ii Study
BLOOD(2018)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要